Eli Lilly’s challenge of Canadian judicial decisions under NAFTA’s Investor-State Dispute Settlement (ISDS) is leading to concerns about ISDS in other trade negotiations. The company alleges that Canada violated its NAFTA obligation to grant patents on any inventions that “are…